Malaria prophylaxis and self-therapy in airline crews.
The risk of malaria infection in airline crews is estimated to be 0.5 per 1,000 persons per night in areas with high levels of malaria transmission. Routine chemoprophylaxis for years is not recommended because of possible side effects. Airline crews should therefore use appropriate measures to prevent mosquito bites. In addition, they may need to carry "standby" medication with them to be used for presumptive treatment of a febrile illness if medical attention is not readily available.
Steffen
R
R
Division of Epidemiology and Prevention of Communicable Diseases, The University, Zurich, Switzerland.
Holdener
F
F
Wyss
R
R
Nurminen
L
L
D000337:Aerospace Medicine; D000349:Africa / Q000453:epidemiology; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D009033:Culicidae; D004338:Drug Combinations; D004351:Drug Resistance; D004630:Emergencies; D006801:Humans; D015994:Incidence; D007299:Insect Bites and Stings / Q000517:prevention & control*; D008288:Malaria / Q000453:epidemiology / Q000517:prevention & control*; D015767:Mefloquine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010349:Patient Compliance; D011481:Protective Clothing; D011739:Pyrimethamine / Q000627:therapeutic use; D012651:Self Medication; D013413:Sulfadoxine / Q000627:therapeutic use; D000096926:Benzenesulfonamides
D000962:Antimalarials; D004338:Drug Combinations; D015767:Mefloquine; D011739:Pyrimethamine; D013413:Sulfadoxine; C001205:fanasil, pyrimethamine drug combination; C046846:mefloquine-sulfadoxine-pyrimethamine; D000096926:Benzenesulfonamides